2024/08/30 RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs corporate 【News_EN】
2024/08/06 RevolKa Started joint research of a drug discovery program for rare diseases 【News_EN】 collab-EN
